Skip to content
  • Twitter
  • Facebook
  • Google Plus
  • Linkedin
  • Youtube
  • Pinterest

Current Medicinal Chemistry.

  • Home
  • FOR AUTHORS
  • ARTICLES
  • SUBSCRIBERS&CORPORATES
  • FOR REVIWERS
  • CONTENTS&ABSTRACTS
  • CONTACT US

Tuesday, January 3, 2017

Most Cited Article: Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A

  1:26 AM bentham   No comments   Edit
Most Cited Article: Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A



Email ThisBlogThis!Share to XShare to Facebook
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
← Newer Post Older Post → Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Open Access Articles

Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review
A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone

Blog Archive

  • ►  2018 (14)
    • ►  May (1)
    • ►  April (5)
    • ►  February (6)
    • ►  January (2)
  • ▼  2017 (72)
    • ►  December (4)
    • ►  November (1)
    • ►  October (7)
    • ►  September (7)
    • ►  August (8)
    • ►  July (7)
    • ►  June (5)
    • ►  May (5)
    • ►  April (6)
    • ►  March (9)
    • ►  February (2)
    • ▼  January (11)
      • New Issue Published Current Medicinal Chemistry
      • Call For Paper
      • New Issue Published Current Medicinal Chemistry Vo...
      • Free Trial Request
      • Most Accessed Article: Transient Tachypnea of the ...
      • Highlighted Article: A New Direction in Ophthalmic...
      • Most Cited Article: What are the Potential Benefit...
      • Most Accessed Article: A Review of Stapled Peptide...
      • Highlighted Article: Should the Incorporation of S...
      • Most Cited Article: Daclatasvir: The First of a Ne...
      • Issue Published Current Medicinal Chemistry Vol. 2...
  • ►  2016 (32)
    • ►  December (11)
    • ►  November (8)
    • ►  October (8)
    • ►  August (1)
    • ►  June (4)

Bentham Science: An Introduction

Bentham Science: An Introduction We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBook

Contact

Subscription Department: Bentham Science Publishers. Executive Suite Y - 2 P.O.Box 7917, Saif Zone Sharjah, U.A.E. Tel: +971-6-5571132 Fax: +971-6-5571134 Email: subscriptions@benthamscience.org

About

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
Copyright © Current Medicinal Chemistry. | Powered by Blogger
Design by currentmedicinalchemistry |